Combined Administration of Bisphosphonates, Chemotherapeutic Agents, and/or Targeted Drugs Increases the Risk for Stage 3 Medication-Related Osteonecrosis of the Jaw: A 4-Year Retrospective Study

Figure 2

The utilization of chemotherapy in different cancer types between two groups. MRONJ patients with administration of chemotherapeutic agents in group A and group B were 11 and 21, respectively. The proportion of every cancer type (%) was the number of different cancer types of patients receiving chemotherapy divided by the total number of MRONJ patients receiving chemotherapy